Babesiosis, Tafenoquine Safety and Ongoing Clinical Studies

This 1 hour webinar presented by Geoff Dow, CEO of 60 Degrees Pharmaceuticals is designed to provide a foundational understanding of babesiosis and Tafenoquine, clinical development program in Babesiosis, a tick-borne parasitic infection, which poses a growing health concern in many regions. The presentation covers:

• Basics of Babesiosis: What it is, how it's transmitted, symptoms, and diagnostic methods.
• Tafenoquine Treatment: An in-depth look at this innovative therapeutic option and overview of the 12 month safety trial for the approved indication of Malaria Prevention.
• Ongoing Clinical Studies: Insights into the latest research for the treatment of Babesiosis.